...
首页> 外文期刊>Frontiers in Molecular Biosciences >CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer
【24h】

CRISPR-Cas13-Mediated Knockdown of lncRNA-GACAT3 Inhibited Cell Proliferation and Motility, and Induced Apoptosis by Increasing p21, Bax, and E-Cadherin Expression in Bladder Cancer

机译:CRISPR-CAS13介导的LNCRNA-GACAT3的敲低抑制细胞增殖和运动,并通过增加膀胱癌中的P21,BAX和E-CDHERIN表达来诱导细胞凋亡

获取原文
           

摘要

The current study is to investigate the expression pattern and biological function of long non-coding RNA Focally gastric cancer-associated transcript3 (GACAT3) in bladder cancer. Real-time quantitative qPCR was used to detect the expression level of GACAT-3 in tumor tissues and paired normal tissues. Human bladder cancer T24 and 5637 cell lines were transiently transfected with specific CRISPR-Cas13 or negative control CRISPR-Cas13. Cell migration, proliferation and apoptosis were measured by using wound healing assay CCK-8 assay and Caspase-3 ELISA assay, respectively. The expression changes of p21, Bax and E-cadherin after knockdown of GACAT3 were detected by using Western blot. The results demonstrated that GACAT3 was up-regulated in bladder cancer tissues than that in the paired normal tissues. Inhibition of cell proliferation, increased apoptosis, and decreased motility were observed in T24 and 5637 cell lines transfected by CRISPR-Cas13 targeting GACAT3. Downregulation of GACAT3 increased p21, Bax and E-cadherin expression and silencing these genes could eliminate the phenotypic changes induced by knockdown of GACAT3. A ceRNA mechanism for GACAT3 was also revealed. By using CRISPR-Cas13 biotechnology,?we suggested that GACAT3 may be a novel target for diagnosis and treatment of bladder cancer.
机译:目前的研究是探讨膀胱癌中长的非编码RNA局部胃癌相关转录3(GACAT3)的表达模式和生物学功能。实时定量QPCR用于检测肿瘤组织中GACAT-3的表达水平和配对的正常组织。用特定CRSPR-CAS13或阴性对照CRS -13瞬时转染人膀胱癌T24和5637细胞系。通过使用伤口愈合测定CCK-8测定和Caspase-3 ELISA测定法测量细胞迁移,增殖和细胞凋亡。通过使用蛋白质印迹检测P21,Bax和E-cadherin后的表达变化。结果表明,GACAT3在膀胱癌组织中上调比配对正常组织中的肿瘤癌组织。在T24和由CRISPR-CAS13靶向GACAT3转染的T24和5637个细胞系中观察到细胞增殖,增加的细胞凋亡和降低的运动。 GACAT3的下调增加了P21,BAX和E-CADHERIN表达和沉默这些基因可以消除GACAT3敲低诱导的表型变化。也揭示了GACAT3的CERNA机制。通过使用CRISPR-CAS13生物技术,我们建议GACAT3可以是膀胱癌的诊断和治疗的新靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号